STOCK TITAN

Alphatec Hldgs Inc SEC Filings

ATEC Nasdaq

Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused medical device company. ATEC uses current reports on Form 8-K to furnish press releases on topics such as quarterly financial results, material corporate events, and board matters. For example, recent 8-K filings reference press releases announcing financial results for periods ended June 30 and September 30, 2025, as well as a release regarding the passing of a member of the Board of Directors.

In addition to 8-Ks, investors typically review ATEC’s annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of its spine surgery business, revenue composition (including surgical and EOS revenue), non-GAAP metrics such as adjusted EBITDA and free cash flow, and risk factors. These periodic reports also describe the company’s Organic Innovation Machine™, InformatiX™ and AlphaInformatiX platforms, and its focus on procedural spine ecosystems.

Regulatory filings can also reflect strategic and capital structure developments, such as refinancings of convertible debt, transaction-related expenses, and non-GAAP adjustments for items like litigation-related expenses, stock-based compensation, and restructuring costs. Forms 3, 4, and 5, when filed, provide insight into insider equity transactions by directors, officers, and significant shareholders.

On Stock Titan, ATEC’s SEC filings are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain the key points of lengthy documents, highlighting items such as revenue trends, segment performance, non-GAAP reconciliations, and notable risk disclosures. For complex filings like 10-Ks and 10-Qs, the AI tools surface essential information so users can quickly understand how Alphatec’s spine-focused strategy, financial profile, and regulatory disclosures are evolving without reading every page.

Rhea-AI Summary

Alphatec Holdings (ATEC) reported an insider transaction: its EVP, Sales sold 70,000 shares of common stock on 10/24/2025 at a weighted average price of $16.18, executed under a Rule 10b5-1 trading plan adopted on June 12, 2025.

After the sale, the reporting person directly owned 461,861 shares. The sales occurred in multiple trades within a price range of $16.15 to $16.29.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Alphatec Holdings (ATEC) reported an insider transaction by its Chief Operating Officer. On 10/14/2025, the officer exercised employee stock options (code M) at $3.35 per share for 13,500 shares of common stock. Following the transaction, the officer beneficially owns 672,207 common shares directly.

The exercised option covered 13,500 underlying shares and carries an expiration date of 03/22/2028. According to the footnote, the grant vested 25% on March 22, 2019 and the remainder in 36 equal monthly installments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a sale of 100,000 shares of the company’s common stock on 10/01/2025 under a Rule 10b5-1 trading plan adopted June 3, 2025. The sales were executed at a weighted average price of $13.96, with individual sale prices ranging from $13.73 to $14.33. After the reported transactions, the filing shows Mr. Patrick beneficially owns 5,464,078 shares directly, plus 10,900 shares in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was signed on 10/02/2025 by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Alphatec Holdings, Inc. (ATEC) Form 144 shows a proposed sale of 300,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $4,362,000. The shares were originally acquired as restricted stock units on 10/02/2020. The filing lists total outstanding shares of 147,983,775 and an approximate planned sale date of 10/01/2025 on NASDAQ. The notice also discloses a related 10b5-1 sale on 09/02/2025 of 300,000 shares that generated gross proceeds of $4,717,830. The filer certifies they are not aware of any undisclosed material adverse information and references reliance on a trading plan or instruction where applicable.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

David Sponsel, Executive Vice President, Sales of Alphatec Holdings, Inc. (ATEC), reported planned sales of common stock under a Rule 10b5-1 trading plan adopted June 12, 2025. The Form 4 shows sales on September 18, 2025 of 137,445 shares at an average price of $15.09 and on September 19, 2025 of 2,555 shares at a weighted average price of $15.34, leaving the reporting person with 531,861 shares beneficially owned after the transactions. The Form 4 was executed by an attorney-in-fact on the reporting dates and discloses that the September 19 price is a weighted average for multiple trades.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Alphatec Holdings, Inc. (ATEC) Form 144 notice: An insider intends to sell 2,555 shares of common stock on approximately 09/19/2025 on NASDAQ with an aggregate market value of $38,887.10 based on the filing. The shares were acquired as restricted stock units (RSUs) on 02/17/2024 and the filer reports the securities were issued by the company. The issuer's total shares outstanding is listed as 147,983,775. The filing also discloses recent 10b5-1 sales by the same person: 137,445 shares sold on 09/18/2025 for $2,073,742.67. The notice includes the standard representation that the selling person does not possess undisclosed material information and references reliance on a trading plan where applicable.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Alphatec Holdings, Inc. (ATEC) submitted a Form 144 notifying the proposed sale of 137,445 common shares through Morgan Stanley Smith Barney LLC on 09/18/2025 with an aggregate market value of $2,020,441.50. The filing shows these shares were acquired on 02/17/2023 as restricted and performance stock units (RSUs & PSUs) from the issuer, and there were no reported sales by the seller in the prior three months.

The shares to be sold represent a small fraction of the 147,983,775 shares outstanding. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. No payment arrangements or gifts are indicated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Mortimer Berkowitz III, a director of Alphatec Holdings, Inc. (ATEC), reported a sale of common stock on 09/09/2025. The Form 4 shows he disposed of 62,500 shares at a weighted-average price of $15.97, reducing his reported direct beneficial ownership to 618,050 shares. The filing also discloses indirect holdings: 24,802 shares held by spouse and 146,575 shares each attributed to four separate 2016 trusts for Charlotte G., Thomas G., Hayward M., and William W. Berkowitz. The footnotes state the sale occurred in multiple transactions at prices ranging from $15.90 to $16.04 and that the reporting person disclaims beneficial ownership of the spouse-held shares except for pecuniary interest. The Form is signed by an attorney-in-fact on behalf of the reporting person on 09/11/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a planned sale of 300,000 shares of ATEC common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted on June 3, 2025. The sales were executed at a weighted average price of $15.73 with individual transaction prices ranging from $15.53 to $15.96. Following the reported disposition, Mr. Patrick beneficially owned 5,564,078 shares directly, plus 10,900 shares held by an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was filed and signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Alphatec Holdings, Inc. (symbol ATEC) submitted a Form 144 notifying a proposed sale of 300,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $4,770,000.00. The reported shares were acquired as Restricted Stock Units on 10/02/2020 and the acquisition and payment date is also listed as 10/02/2020. The filing shows 147,983,775 shares outstanding, and an approximate date of sale of 09/02/2025. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the selling person does not possess undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Alphatec Hldgs (ATEC)?

The current stock price of Alphatec Hldgs (ATEC) is $17.74 as of January 16, 2026.

What is the market cap of Alphatec Hldgs (ATEC)?

The market cap of Alphatec Hldgs (ATEC) is approximately 2.6B.
Alphatec Hldgs Inc

Nasdaq:ATEC

ATEC Rankings

ATEC Stock Data

2.59B
117.12M
20.83%
69.1%
8.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CARLSBAD

ATEC RSS Feed